Release Date: 20/05/16 16:56 Summary: Results of Meeting-SKI.AX Price Sensitive: No Download Document 249.45KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%